Structure-Based Design of (5-Arylamino-2H-pyrazol-3-yl)-biphenyl-2‘,4‘-diols as Novel and Potent Human CHK1 Inhibitors
Teng, Min, Zhu, Jinjiang, Johnson, Michael D, Chen, Ping, Kornmann, Jill, Chen, Enhong, Blasina, Alessandra, Register, James, Anderes, Kenna, Rogers, Caroline, Deng, Yali, Ninkovic, Sacha, Grant, Stephan, Hu, Qiyue, Lundgren, Karen, Peng, Zhengwei, Kania, Robert S
Published in Journal of medicinal chemistry (01.11.2007)
Published in Journal of medicinal chemistry (01.11.2007)
Get full text
Journal Article
Combined gemcitabine and CHK1 inhibitor treatment induces apoptosis resistance in cancer stem cell-like cells enriched with tumor spheroids from a non-small cell lung cancer cell line
Fang, Douglas D., Cao, Joan, Jani, Jitesh P., Tsaparikos, Konstantinos, Blasina, Alessandra, Kornmann, Jill, Lira, Maruja E., Wang, Jianying, Jirout, Zuzana, Bingham, Justin, Zhu, Zhou, Gu, Yin, Los, Gerrit, Hostomsky, Zdenek, VanArsdale, Todd
Published in Frontiers of medicine (01.12.2013)
Published in Frontiers of medicine (01.12.2013)
Get full text
Journal Article
Structure-based design and synthesis of (5-arylamino-2H-pyrazol-3-yl)-biphenyl-2',4'-diols as novel and potent human CHK1 inhibitors
Teng, Min, Zhu, Jinjiang, Johnson, Michael D, Chen, Ping, Kornmann, Jill, Chen, Enhong, Blasina, Alessandra, Register, James, Anderes, Kenna, Rogers, Caroline, Deng, Yali, Ninkovic, Sacha, Grant, Stephan, Hu, Qiyue, Lundgren, Karen, Peng, Zhengwei, Kania, Robert S
Published in Journal of medicinal chemistry (01.11.2007)
Get full text
Published in Journal of medicinal chemistry (01.11.2007)
Journal Article